Compare Affirm Holdings Inc (AFRM) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Affirm Holdings Inc vs GeneDx Holdings Corp — how do they compare? Affirm Holdings Inc trades at $75.43 (market cap $25.69B), while GeneDx Holdings Corp trades at $82.37 (market cap $2.44B). The key difference: Affirm Holdings Inc is far larger — about 10.5× GeneDx Holdings Corp's market cap, and Affirm Holdings Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| AFRM | WGS | |
|---|---|---|
Market Cap | $25.69B | $2.44B |
Sector | Financials | Technology |
52-Week High | $92.18 | $167.51 |
52-Week Low | $42.53 | $34.51 |
Enterprise Value | $32.30B | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AFRM trades at $75.54, up 0.39% today, with a bullish technical signal and consistent earnings beats. Revenue grew to $3.22B in 2025, turning profitable with $52M net income. The stock faces resistance near $76-$78, while analyst consensus targets $96.40, implying 28% upside. Recent news highlights strong growth prospects and institutional interest.
Outlook is positive given accelerating revenue growth, expanding margins, and dominant buy-side analyst support. Key risks include high valuation multiples (P/E 69.7) and sensitivity to interest rate changes, but robust cash flow generation and market share gains support long-term upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
